Theravance Biopharma (TBPH) Inventory Average (2014 - 2018)
Theravance Biopharma (TBPH) posted quarterly Inventory Average of $17.9 million for Q3 2018, up 30.84% year-over-year from $13.7 million in Q3 2017, and up 2.01% quarter-over-quarter from $17.6 million in Q2 2018.
Theravance Biopharma (TBPH) Inventory Average (2014 - 2018) Analysis & Trends
Theravance Biopharma (TBPH) has reported Inventory Average for 5 consecutive years, with $17.9 million the latest figure, recorded in Q3 2018.
- In Q3 2018, Inventory Average rose 30.84% year-over-year to $17.9 million; the TTM figure through Sep 2018 stood at $17.9 million (up 30.84% YoY), while the FY2017 annual figure was $14.5 million, up 30.71% from the prior year.
- Inventory Average rose to $17.9 million in Q3 2018 per TBPH's latest filing, from $17.6 million in the prior quarter.
- Across five years, Inventory Average topped out at $17.9 million in Q3 2018 and bottomed at $9.6 million in Q2 2016.
- Historically, Inventory Average has averaged $13.2 million across 5 years, with a median of $12.7 million in 2017.
- Annual changes were most pronounced in 2016 — Inventory Average slipped 22.8% — and 2018, when it soared 38.6%.
- Theravance Biopharma's Inventory Average stood at $13.8 million in 2014, then retreated by 19.98% to $11.1 million in 2015, then gained by 11.53% to $12.4 million in 2016, then grew by 29.91% to $16.0 million in 2017, then advanced by 11.66% to $17.9 million in 2018.
- Business Quant data shows TBPH's Inventory Average at $17.9 million in Q3 2018, $17.6 million in Q2 2018, and $17.0 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 17.91 Mn |
| Jun 30, 2018 | 17.56 Mn |
| Mar 31, 2018 | 17.02 Mn |
| Dec 31, 2017 | 16.04 Mn |
| Sep 30, 2017 | 13.69 Mn |
| Jun 30, 2017 | 12.67 Mn |
| Mar 31, 2017 | 12.72 Mn |
| Dec 31, 2016 | 12.35 Mn |
| Sep 30, 2016 | 11.15 Mn |
| Jun 30, 2016 | 9.61 Mn |
| Mar 31, 2016 | 9.71 Mn |
| Dec 31, 2015 | 11.07 Mn |
| Sep 30, 2015 | 12.35 Mn |
| Jun 30, 2015 | 12.45 Mn |
| Mar 31, 2015 | 12.44 Mn |
| Dec 31, 2014 | 13.84 Mn |
| Sep 30, 2014 | 14.94 Mn |
| Jun 30, 2014 | 12.89 Mn |
| Mar 31, 2014 | 10.71 Mn |